© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Liver Meeting 2015

Click Here for More Conferences
Click Here for AASLD.org
An Introduction to Hepatitis
Oriol R. Gutierrez

Pretty Woman

Getting access to the new hep C drugs remains an ongoing barrier for too many people, but the drugs keep getting better.

High Marks for Merck’s Hep C Treatment in Those With HIV

Merck’s investigational hepatitis C treatment grazoprevir/elbasvir cured high rates of the virus among individuals coinfected with HIV.

Success in Adding Sovaldi to Hep C Re-treatment Regimens

Individuals who have failed hepatitis C treatment may ultimately achieve a cure if they add Sovaldi (sofosbuvir) to a subsequent treatment reg...

Less Liver Fibrosis for Coffee Drinkers With Hep B or C

Drinking coffee is linked with reduced liver fibrosis among people with hepatitis B, hepatitis C, and non-alcoholic fatty liver disease.

More Good Hep C Cure Rates for Sovaldi/Velpatasvir

Sovaldi and velpatasvir, with/without ribavirin, yielded good results among people with various genotypes of HCV and decompensated cirrhosis

Good Results for Sovaldi and Ravidasvir Treating Hepatitis C Genotype 4

Twelve or 16 weeks of Sovaldi (sofosbuvir) and ravidasvir cured high rates of people with genotype 4 of hepatitis C virus in a recent large tr...

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

8 Weeks of Harvoni + Vedroprevir Cures 96% of Hard-to-Treat Hep C

8 weeks of Harvoni (ledipasvir/sofosbuvir) and vedroprevir boasted a near-perfect cure rate among those with genotype 1 and advanced liver dis...

Gilead’s Sovaldi/Velpatasvir Cures High Rates of All Hep C Genotypes

Gilead Sciences Sovaldi (sofosbuvir) and velpatasvir posted near-perfect results in curing an array of genotypes of hepatitis C.

Reflections of a Hepatitis C Advocate

Long time health advocate Bill Remak’s reflections on the 2015 AASLD Liver Meeting and hepatitis C advocacy

Hepatitis C Cure Often Leads to Improvement in Liver Health

Those with advanced fibrosis or cirrhosis who are cured of hepatitis C often experience regression of liver damage, improving by at least one...

Daklinza & Sovaldi Better Treats Those With HIV & HCV

Daklinza (daclatasvir) and Sovaldi (sofosbuvir) more effectively cures hepatitis C among those coinfected with HIV than does Sovaldi and...

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Near-Perfect Results for New AbbVie Hep C Combo in Genotype 1s

Eight or 12 weeks of AbbVie’s investigational hepatitis C treatments ABT-493 and ABT-530 cured 97 to 100 percent of people with genotype 1.

High Genotype 2 and 3 Hep C Cure Rates for New AbbVie Combo

AbbVie’s investigational hepatitis C treatments ABT-493 and ABT-530 posted mostly high cure rates among people with genotypes 2 and 3.

Today’s Hep C Drugs May Avert Many Liver Transplants

The high success rate of today’s hepatitis C treatments may keep many people from needing a liver transplant.

Promising Results for REP 2139 Treating Hep B and D Coinfection

A nucleic acid-based polymer called REP 2139, given alone and with interferon, has shown promise treating coinfection with hep B and hep D.

Elbasvir/Grazoprevir Hep C Regimen Succeeds in Opiate Addicts

Elbasvir/grazoprevir cured high rates of individuals with genotypes 1, 4 or 6 of hepatitis C who inject drugs and are receiving opioid agonist...
Advertisement
Treatment News
Newsfeed
Features
Ask Hep